Mutual of America Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
RI
ACM
MB
Mutual of America Capital Management's RGNX Position: Q4 2022 in Review
Mutual of America Capital Management sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 7,483 shares — an estimated $198K sold.
Mutual of America Capital Management first reported a position in RGNX in Q2 2018 and held it in 18 quarters. The position peaked at $210K in Q3 2021. 182 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.
- Mutual of America Capital Management reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
- Mutual of America Capital Management sold 7,483 Regenxbio shares in Q4 2022, an estimated $198K.
- Mutual of America Capital Management first reported a position in Regenxbio in Q2 2018 and held it in 18 quarters.
- Mutual of America Capital Management's Regenxbio position peaked at $210K in Q3 2021.
- 182 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.
Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.